Stockscreener 앱 받기
24.16
4.36%
1.01
시간 외 거래:
24.16
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Hims & Hers Health stock: Daily momentum and support levels drive a 3.41% advance - Traders Union
Novo Nordisk Secures FDA Approval For Higher-Dose Wegovy - Benzinga
Buying pressure lifts Hims & Hers Health stock higher in today's trading - Traders Union
Understanding Momentum Shifts in (HIMS) - Stock Traders Daily
Insider Sell: Irene Becklund Sells Shares of Hims & Hers Health Inc (HIMS) - GuruFocus
Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Hims & Hers Health Faces Another Legal Setback Amid Probes and Falling Shares - StocksToTrade
Insider Selling: Hims & Hers Health (NYSE:HIMS) COO Sells 97,289 Shares of Stock - MarketBeat
Hims & Hers Health (NYSE:HIMS) Insider Sells $136,511.01 in Stock - MarketBeat
Hims & Hers health COO Chi sells $2.4m in shares - Investing.com
Top Healthcare Stocks To Follow TodayMarch 18th - MarketBeat
Hims & Hers Opens Waitlist For $149 Branded Wegovy And Ozempic Via Novo Nordisk Deal - Benzinga
Hims & Hers Opens Up Pre-Launch Waitlist For Ozempic And Wegovy Following Partnership With Novo Nordisk - Stocktwits
Telemedicine company Hims & Hers Health Inc. (NYSE: HIMS) announced that its service platform will expand its product range to include Novo Nordisk's Wegovy® (semaglutide) oral tablets and injections, as well as Ozempic® injections. - Bitget
A New Era of Weight Management is Coming to Hims & Hers - Hims & Hers Newsroom
Greenfield Seitz Capital Management LLC Sells 43,334 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock's Surprise Move - Yahoo Finance
Healthcare Stocks To ConsiderMarch 17th - MarketBeat
HIMS Stock: After a 57% Surge, Is It Time to Buy Hims & Hers? - CMC Markets
Hims & Hers Health shares see a dip — What is pressuring the stock - Traders Union
Hims & Hers Health, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Aquatic Capital Management LLC Purchases New Stake in Hims & Hers Health, Inc. $HIMS - MarketBeat
Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader Market - MSN
HIMS: Leerink Partners Raises Price Target to $25.00 | HIMS Stoc - GuruFocus
Hims And Hers Health Pushes Into Complex Care And Global Growth - Yahoo Finance
HIMS Expands Personalized Digital Healthcare Access and Services - The Globe and Mail
Hims & Hers Health Stock Slips After Surging 50% In A Month - Benzinga
Novo Nordisk & Hims & Hers: Supply Deal for Ozempic and WegovyNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
What is behind Hims & Hers Health stock's recent drop in value today - Traders Union
Why the Novo Nordisk and Hims & Hers deal is a win for both stocks - MSN
Why the Novo Nordisk and Hims & Hers Deal Is a Win for Both Stocks - Yahoo Finance
Farallon Capital Management LLC Purchases 2,533,271 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers under fire over copycat weight loss drugs - WNTZ-TV FOX 48
Hims & Hers Health (HIMS) Is Up 57.4% After Renewed Novo Nordisk GLP-1 PartnershipHas The Bull Case Changed? - simplywall.st
Hims & Hers Stock Soars on Strategic Pivot with Novo Nordisk - AD HOC NEWS
Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now? - Insider Monkey
Clear Street Group Inc. Invests $87.37 Million in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers (HIMS) Soars 57.4% on New Deal - Insider Monkey
A Look At Hims & Hers Health (HIMS) Valuation After A Sharp 57% Weekly Share Price Move - simplywall.st
Hims & Hers posts best weekly gain after Novo deal - Seeking Alpha
OWL, HIMS, TSLA And More: 5 Stocks Investors Couldn't Stop Buzzing About This WeekOracle (NYSE:ORCL) - Benzinga
Hims & Hers Health, Inc. Class A Trade Ideas — SWB:82W - TradingView
Telehealth Giant Hims Partners with Novo Nordisk After Dropping Legal Battle - Fine Day 102.3
Hims And Hers Health Weighs Eucalyptus Deal Against Growth And Valuation Risks - simplywall.st
Weekly Market Update: Stocks Slide as Financials, Consumer Cyclicals Fall - Morningstar
Hims & Hers Stock Skyrockets Amid Novo Nordisk Partnership - StocksToTrade
Hims Shares Notch Record Week as Novo Pact Spurs Optimism - Yahoo Finance
Hims & Hers (HIMS) sees analyst optimism following Novo resolution - MSN
Hims & Hers (HIMS) Sees Analyst Optimism Following Novo Resolution - Insider Monkey
Selling pressure pushes Hims & Hers Health stock lower in today's trading - Traders Union
Hims & Hers class action alleges semaglutide GLP-1 products falsely advertised - Class Action Lawsuits
Barclays raises PT on Hims & Hers Health (HIMS) stock - MSN
Hims shares set for record week as Novo partnership fuels optimism - Modern Healthcare
Barclays Raises PT on Hims & Hers Health (HIMS) Stock - Insider Monkey
Hims & Hers Health stock price steadies after wild Novo week as focus shifts to margins - TechStock²
Hims shares set for best week on record after new Novo Nordisk deal - Investing.com
Hims Shares Set for Record Week as New Novo Pact Fuels Optimism - Bloomberg.com
Quantitative Investment Management LLC Makes New Investment in Hims & Hers Health, Inc. $HIMS - MarketBeat
5 Best Day Trading Stocks to Buy Now - Insider Monkey
Hims & Hers Stock Jumps After Novo Nordisk Deal. What It Means for Drugmaker - TradingView
Investor relations - HIMS Investor Relations
12 Most Shorted Stocks to Buy in 2026 - Insider Monkey
Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications - MSN
‘They Need Each Other’: Why Hims & Hers and Novo Nordisk Made Up - MedCity News
Hims & Hers stock takes a major hit amid multiple investigations and target cuts - StocksToTrade
Stock Market Today, March 12: Hims and Hers Health Drops After Rally Sparks Profit Taking - Yahoo Finance
Hims And Hers Benefits Aims To Deepen Member Loyalty And Engagement - simplywall.st
Hims & Hers Health, Inc. (HIMS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Hims & Hers Faces Investigation Amid Wegovy Sales Discontinuation - timothysykes.com
2.02%
0.77%
자본화:
|
볼륨(24시간):